These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27184069)

  • 1. The Past, Present, and Future of Genetic Manipulation in Toxoplasma gondii.
    Wang JL; Huang SY; Behnke MS; Chen K; Shen B; Zhu XQ
    Trends Parasitol; 2016 Jul; 32(7):542-553. PubMed ID: 27184069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9.
    Shen B; Brown KM; Lee TD; Sibley LD
    mBio; 2014 May; 5(3):e01114-14. PubMed ID: 24825012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9-Mediated Generation of Tetracycline Repressor-Based Inducible Knockdown in Toxoplasma gondii.
    Jacot D; Soldati-Favre D
    Methods Mol Biol; 2020; 2071():125-141. PubMed ID: 31758450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Noncanonical Calcium-Dependent Protein Kinases in Toxoplasma gondii by Targeted Gene Deletion Using CRISPR/Cas9.
    Long S; Wang Q; Sibley LD
    Infect Immun; 2016 May; 84(5):1262-1273. PubMed ID: 26755159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the basic functions of six calcium-dependent protein kinases in Toxoplasma gondii using CRISPR-Cas9 system.
    Wang JL; Huang SY; Li TT; Chen K; Ning HR; Zhu XQ
    Parasitol Res; 2016 Feb; 115(2):697-702. PubMed ID: 26499803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved method for introducing site-directed point mutation into the Toxoplasma gondii genome using CRISPR/Cas9.
    Sugi T; Kato K; Weiss LM
    Parasitol Int; 2016 Oct; 65(5 Pt B):558-562. PubMed ID: 27167504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AID-ing Signaling in
    Kim K
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic manipulation of the Toxoplasma gondii genome by fosmid recombineering.
    Vinayak S; Brooks CF; Naumov A; Suvorova ES; White MW; Striepen B
    mBio; 2014 Dec; 5(6):e02021. PubMed ID: 25467441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockout of leucine aminopeptidase in Toxoplasma gondii using CRISPR/Cas9.
    Zheng J; Jia H; Zheng Y
    Int J Parasitol; 2015 Feb; 45(2-3):141-8. PubMed ID: 25444863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the CRISPR/Cas9 gene editing technique to research on functional genomes of parasites.
    Cui Y; Yu L
    Parasitol Int; 2016 Dec; 65(6 Pt A):641-644. PubMed ID: 27586395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxoplasma gondii: the model apicomplexan.
    Kim K; Weiss LM
    Int J Parasitol; 2004 Mar; 34(3):423-32. PubMed ID: 15003501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome modification by CRISPR/Cas9.
    Ma Y; Zhang L; Huang X
    FEBS J; 2014 Dec; 281(23):5186-93. PubMed ID: 25315507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of somatic CRISPR-Cas9 to conditional genome editing in Caenorhabditis elegans.
    Li W; Ou G
    Genesis; 2016 Apr; 54(4):170-81. PubMed ID: 26934570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9.
    Ren J; Zhao Y
    Protein Cell; 2017 Sep; 8(9):634-643. PubMed ID: 28434148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic manipulation in Δku80 strains for functional genomic analysis of Toxoplasma gondii.
    Rommereim LM; Hortua Triana MA; Falla A; Sanders KL; Guevara RB; Bzik DJ; Fox BA
    J Vis Exp; 2013 Jul; (77):e50598. PubMed ID: 23892917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moving towards an integrated approach to molecular detection and identification of Toxoplasma gondii.
    Su C; Shwab EK; Zhou P; Zhu XQ; Dubey JP
    Parasitology; 2010 Jan; 137(1):1-11. PubMed ID: 19765337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhoptry protein 47 gene sequence: A potential novel genetic marker for population genetic studies of Toxoplasma gondii.
    Wang JL; Li TT; Li ZY; Huang SY; Ning HR; Zhu XQ
    Exp Parasitol; 2015 Jul; 154():1-4. PubMed ID: 25862398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling Disease In Vivo With CRISPR/Cas9.
    Dow LE
    Trends Mol Med; 2015 Oct; 21(10):609-621. PubMed ID: 26432018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of genome editing in studying hearing loss.
    Zou B; Mittal R; Grati M; Lu Z; Shu Y; Tao Y; Feng Y; Xie D; Kong W; Yang S; Chen ZY; Liu X
    Hear Res; 2015 Sep; 327():102-8. PubMed ID: 25987504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIC16 gene represents a potential novel genetic marker for population genetic studies of Toxoplasma gondii.
    Liu WG; Xu XP; Chen J; Xu QM; Luo SL; Zhu XQ
    BMC Microbiol; 2016 Jun; 16():101. PubMed ID: 27277196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.